Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 medications represent a breakthrough in weight management, with clinical trials showing an average weight loss of 15-22% over one year when combined with lifestyle changes. These medications work by mimicking glucagon-like peptide-1, a natural hormone your body produces to control hunger and blood glucose levels. Understanding how GLP-1 therapy functions can help you decide if it aligns with your weight loss goals.
How Does GLP-1 Medication Work in Your Body?
GLP-1 receptor agonists bind to specific receptors in your brain's appetite centers, signaling fullness and reducing your desire to eat. This mechanism targets the hypothalamus, the region responsible for hunger regulation, allowing you to feel satisfied with smaller portions. Unlike stimulant-based weight loss drugs, GLP-1 medications work with your body's natural hormonal pathways rather than forcing energy expenditure.
Beyond appetite suppression, GLP-1 agonists slow gastric emptying—the rate at which food moves from your stomach to your small intestine. This extended digestion period keeps you feeling full longer and stabilizes blood sugar fluctuations that typically trigger cravings. The medication also increases insulin secretion when blood glucose rises, helping prevent the energy crashes that often derail weight loss efforts.
Your liver and pancreas respond to GLP-1 signaling by improving their metabolic efficiency. This dual action on hunger centers and metabolic regulation is why GLP-1 therapy produces consistent, sustainable weight loss across diverse patient populations, regardless of baseline BMI or previous diet attempts.
Semaglutide Injection vs. Other GLP-1 Options
Semaglutide is a GLP-1 receptor agonist available in both injection and oral formulations. PlexusDx compounded semaglutide injection starts at $149 per month and is prepared by licensed 503A compounding pharmacies, ensuring pharmaceutical-grade purity and potency. Injectable semaglutide typically demonstrates faster therapeutic onset and more consistent absorption compared to oral formulations, allowing your dose to reach therapeutic levels more predictably.
Oral semaglutide offers convenience for patients who prefer tablet administration, beginning at $249 per month through PlexusDx. However, oral versions require specific administration protocols—taking the medication on an empty stomach with limited water—to maximize absorption. PlexusDx also offers tirzepatide, a dual GLP-1 and GIP receptor agonist starting at $249 monthly for injection, which some patients find produces more rapid initial weight reduction.
Choosing between semaglutide injection, oral semaglutide, or tirzepatide depends on your lifestyle preferences, injection comfort level, and response to initial therapy. PlexusDx offers the Precision Peptide Genetic Test for $99 as an add-on after your first month, analyzing 14 metabolic pathways across 150+ genetic insights to predict which compound may align best with your unique peptide-pathway genetics.
Clinical Evidence: Real Weight Loss Results with GLP-1 Therapy
The STEP 1-5 clinical trials demonstrated that participants taking semaglutide lost an average of 15 to 22 pounds over 68 weeks compared to 2-3 pounds in placebo groups. These results included diverse populations across different baseline weights, showing that GLP-1 medications work effectively for people ranging from overweight to Class III obesity categories. Long-term follow-up data indicates that weight loss persists as long as the medication remains part of your treatment regimen.
Beyond weight loss alone, semaglutide and tirzepatide show improvements in cardiovascular risk markers—including reductions in systolic blood pressure, triglycerides, and fasting glucose levels. A landmark cardiovascular outcomes trial showed semaglutide reduced major adverse cardiac events by 26% in patients with established heart disease. These metabolic improvements occur independently of weight loss, suggesting GLP-1 medications provide systemic health benefits that extend beyond the scale.
Response timelines vary by individual, with most patients experiencing noticeable appetite reduction within 2-4 weeks of starting therapy. Peak weight loss typically occurs between 16-24 weeks, after which the rate of loss plateaus as your body adjusts to the medication. PlexusDx supports gradual, sustainable weight management rather than rapid loss, reflecting the evidence that slower weight reduction produces better long-term maintenance and metabolic adaptation.
Starting GLP-1 Treatment: What to Expect on Your First Month
Your GLP-1 journey with PlexusDx begins with a telehealth consultation to assess your medical history, current medications, and weight loss objectives. If you are a suitable candidate, PlexusDx provides either semaglutide injection (starting at $149 monthly) or oral formulations, with your initial dose carefully selected to minimize side effects while establishing therapeutic efficacy. All medications ship from licensed 503A compounding pharmacies directly to your home, with no insurance requirement or membership fees.
The first 2-3 weeks typically involve mild adaptation as your body adjusts to increased satiety and reduced food cravings. Some patients experience mild nausea, constipation, or changes in appetite, which generally resolve as your system acclimates to the medication. PlexusDx provides ongoing clinical support to monitor your progress, address concerns, and adjust your dose if needed—with the pricing guarantee that your dose may increase, but your monthly cost remains flat.
Starting treatment is HSA- and FSA-eligible through PlexusDx, making it financially accessible for patients with qualifying health savings accounts. After completing your first month of treatment, you become eligible for the optional Precision Peptide Genetic Test ($99 add-on), which analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to predict your metabolic response and optimize long-term therapy selection.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide as effective as brand-name Ozempic or Wegovy?
PlexusDx compounded semaglutide is manufactured by licensed 503A compounding pharmacies to pharmaceutical-grade standards and contains the same active compound as brand medications. The primary difference is cost—PlexusDx semaglutide injection starts at $149 monthly, significantly less than brand alternatives, while delivering equivalent therapeutic outcomes.
How much weight can I realistically lose with GLP-1 therapy?
Clinical trials show average weight loss of 15-22% of baseline body weight over one year with semaglutide, though individual results vary based on starting weight, lifestyle adherence, and genetic factors. PlexusDx offers the Precision Peptide Genetic Test to identify your unique peptide-pathway response, potentially predicting your personalized weight loss trajectory.
Does PlexusDx serve my state, and do I need insurance?
PlexusDx delivers GLP-1 medications to all 50 states without requiring insurance coverage. Treatment is HSA- and FSA-eligible, and there are no membership fees or hidden costs—your semaglutide injection starts at $149 monthly flat-rate pricing.
What are the most common side effects, and are they permanent?
Mild nausea, constipation, and reduced appetite are typical in the first 2-4 weeks as your body adjusts to GLP-1 signaling. These effects usually resolve within days to weeks as your system acclimates. Serious side effects are rare but may include pancreatitis or gallbladder issues; PlexusDx clinical support monitors your safety throughout treatment.
How does the Precision Peptide Genetic Test improve my results?
PlexusDx Precision Peptide Genetic Test ($99) analyzes your GLP1R, GIPR, FTO, and MC4R variants across 14 metabolic pathways, identifying genetic predispositions that influence how your body responds to semaglutide versus tirzepatide. This allows your provider to select the compound most likely to produce optimal weight loss and minimize side effects based on your unique genetics.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Demystifying Your Ozempic Pen: How Many Doses Are Inside?
How Much Weight Can I Lose on Ozempic? Insights and Expectations